Not applicableStudy completedNCT02452840What this trial is testingPhotodynamic Therapy for PDA in NV AMDWho this might be right forNeovascular Age-related Macular DegenerationMacular Degeneration Duke University 100
Early research (Phase 1)Study completedNCT00109499What this trial is testingStudy of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)Who this might be right forMacular Degeneration GenVec
Testing effectiveness (Phase 2)UnknownNCT05859776What this trial is testingSafety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular Degeneration AsclepiX Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT02571972What this trial is testingDorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.Who this might be right forWet Macular DegenerationAge-related Macular DegenerationDiabetic Macular Edema+1 more Wills Eye 14
Large-scale testing (Phase 3)Study completedNCT04690556What this trial is testingStudy to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMDWho this might be right forNeovascular Age-related Macular Degeneration Lupin Ltd. 600
Large-scale testing (Phase 3)Ended earlyNCT01944839What this trial is testingSafety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® MonotherapyWho this might be right forAge-Related Macular Degeneration Ophthotech Corporation 619
Early research (Phase 1)Study completedNCT02591914What this trial is testingAn Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Retinal Consultants of Arizona 30
Testing effectiveness (Phase 2)Ended earlyNCT01025232What this trial is testingIntravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)Who this might be right forAge Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more David M. Brown, M.D. 88
Large-scale testing (Phase 3)Study completedNCT06190093What this trial is testingA 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)Who this might be right forNeovascular Age-related Macular DegenerationAge-Related Macular DegenerationWet Macular Degeneration Outlook Therapeutics, Inc. 400
Large-scale testing (Phase 3)Study completedNCT02611778What this trial is testingEfficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration (AMD) Bioeq GmbH 712
Not applicableStudy completedNCT05111743What this trial is testingReal-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)Who this might be right forAge-related Macular Degeneration (AMD) Novartis Pharmaceuticals 9,261
Not applicableUnknownNCT03688243What this trial is testingNon Exudative AMD Imaged With SS-OCTWho this might be right forDry Macular Degeneration Boston Image Reading Center 225
Large-scale testing (Phase 3)Study completedNCT00590694What this trial is testingLucentis for Age-related Macular Degeneration Pigment Epithelial DetachmentsWho this might be right forAge-related Macular DegenerationPigment Epithelial DetachmentNeovascular Macular Degeneration+1 more Pacific Eye Associates 15
Post-approval studies (Phase 4)Study completedNCT02321839What this trial is testingEvaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.Who this might be right forNeovascular Age-related Macular Degeneration Nagoya City University 78
Not applicableStudy completedNCT03411941What this trial is testingEvaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forMacular Degeneration Bayer 116
Not applicableLooking for participantsNCT03577041What this trial is testingMedico-economic Evaluation of Anti-VEGF Treatments in the Treatment of naïve Age-related Macular Degeneration (AMD): a Model Adapted to the French ContextWho this might be right forAge-related Macular Degeneration (AMD) Centre Hospitalier Universitaire, Amiens 600
Post-approval studies (Phase 4)Study completedNCT01775124What this trial is testingEfficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)Who this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 332
Large-scale testing (Phase 3)Looking for participantsNCT06847542What this trial is testing36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMDWho this might be right forNeovascular Age-related Macular Degeneration Hoffmann-La Roche 250
Early research (Phase 1)Study completedNCT05639530What this trial is testingA Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Innovent Biologics (Suzhou) Co. Ltd. 17
Large-scale testing (Phase 3)Ended earlyNCT00065728What this trial is testingOpen-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMDWho this might be right forMacular Degeneration Alcon Research 111